Surgical and radiosurgical management of brain metastases

被引:26
作者
Barker, FG
机构
[1] Massachusetts Gen Hosp, Brain Tumor Ctr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1016/j.suc.2004.11.003
中图分类号
R61 [外科手术学];
学科分类号
摘要
Approximately 10% to 15% of all patients who have cancer will be diagnosed with brain metastases in the Course of their illness, although the incidence in autopsy studies is greater [1,2]. Most patients live less than a year after diagnosis of brain metastases; however, it probably is the specter of physical and mental disability during that time that is feared most by patients and families. Not all morbidity from brain metastases can be avoided or reversed, but aggressive local treatment is now known to benefit many patients who have one or a few brain metastases. These treatments (surgical resection or focused radiation) are the main subject of this article.
引用
收藏
页码:329 / +
页数:18
相关论文
共 96 条
[1]   Temozolomide for the treatment of brain metastases associated with metastatic melanoma: A phase II study [J].
Agarwala, SS ;
Kirkwood, JM ;
Gore, M ;
Dreno, B ;
Thatcher, N ;
Czarnetski, B ;
Atkins, M ;
Buzaid, A ;
Skarlos, D ;
Rankin, EM .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2101-2107
[2]   The origin of brain metastases in patients with an undiagnosed primary tumour [J].
Agazzi, S ;
Pampallona, S ;
Pica, A ;
Vernet, O ;
Regli, L ;
Porchet, F ;
Villemure, JG ;
Leyvraz, S .
ACTA NEUROCHIRURGICA, 2004, 146 (02) :153-157
[3]   Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].
Andrews, DW ;
Scott, CB ;
Sperduto, PW ;
Flanders, AE ;
Gaspar, LE ;
Schell, MC ;
Werner-Wasik, M ;
Demas, W ;
Ryu, J ;
Bahary, JP ;
Souhami, L ;
Rotman, M ;
Mehta, MP ;
Curran, WJ .
LANCET, 2004, 363 (9422) :1665-1672
[4]  
ARBIT E, 1995, CANCER, V76, P765, DOI 10.1002/1097-0142(19950901)76:5<765::AID-CNCR2820760509>3.0.CO
[5]  
2-E
[6]  
ASAI A, 1989, CANCER-AM CANCER SOC, V63, P1962, DOI 10.1002/1097-0142(19890515)63:10<1962::AID-CNCR2820631016>3.0.CO
[7]  
2-V
[8]   Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission [J].
Aupérin, A ;
Arriagada, R ;
Pignon, JP ;
Le Péchoux, C ;
Gregor, A ;
Stephens, RJ ;
Kristjansen, PEG ;
Johnson, BE ;
Ueoka, H ;
Wagner, H ;
Aisner, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) :476-484
[9]   The effect of temozolomide-based chemotherapy in patients with cerebral metastases from melanoma [J].
Bafaloukos, D ;
Tsoutsos, D ;
Fountzilas, G ;
Linardou, H ;
Christodoulou, C ;
Kalofonos, HP ;
Briassoulis, E ;
Panagiotou, P ;
Hatzichristou, H ;
Gogas, H .
MELANOMA RESEARCH, 2004, 14 (04) :289-294
[10]   Craniotomy for the resection of metastatic brain tumors in the US, 1988-2000 - Decreasing mortality and the effect of provider caseload [J].
Barker, FG .
CANCER, 2004, 100 (05) :999-1007